Edwards Lifesciences (EW) Other financing activities (2009 - 2026)

Edwards Lifesciences' Other financing activities history runs 18 years deep, the most recent figure standing at $1.7 million for Q1 2026.

• In Q1 2026, Other financing activities rose 142.86% year-over-year to $1.7 million; the TTM figure through Mar 2026 stood at -$2.8 million (down 27.27% YoY), while the FY2025 annual figure was -$3.8 million, down 22.58% from the prior year.
• Other financing activities was $1.7 million for Q1 2026 at Edwards Lifesciences, up from -$3.1 million in the prior quarter.
• In the past five years, Other financing activities ranged from a high of $7.2 million in Q2 2024 to a low of -$10.2 million in Q3 2024.
• Historically, Other financing activities has averaged -$643750.0 across 5 years, with a median of -$50000.0 in 2022.
• The sharpest annual moves came in 2023 and 2025: Other financing activities jumped 1900.0% in 2023, then tumbled 3200.0% in 2025.
• A 5-year view of Other financing activities shows it stood at $100000.0 in 2022, then surged by 1900.0% to $2.0 million in 2023, then plunged by 95.0% to $100000.0 in 2024, then sank by 3200.0% to -$3.1 million in 2025, then surged by 154.84% to $1.7 million in 2026.
• The last three Other financing activities figures came in at $1.7 million (Q1 2026), -$3.1 million (Q4 2025), and -$2.4 million (Q3 2025), per Business Quant data.